0001610717-24-000019.txt : 20240108 0001610717-24-000019.hdr.sgml : 20240108 20240108190408 ACCESSION NUMBER: 0001610717-24-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240104 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lanfear Dennis M CENTRAL INDEX KEY: 0001420822 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 24521414 MAIL ADDRESS: STREET 1: C/O COHERUS BIOSCIENCES, INC. STREET 2: 333 TWIN DOLPHIN DRIVE, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 4 1 form4.xml X0508 4 2024-01-04 0001512762 Coherus BioSciences, Inc. CHRS 0001420822 Lanfear Dennis M C/O COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 true true President & CEO false Common Stock 2024-01-04 4 F 0 11781 2.92 D 719912 D Common Stock 432684 I By Trust Common Stock 86965 I By LLC Stock Option (Right to Buy) 3.14 2024-01-05 4 A 0 575000 0 A 2034-01-05 Common Stock 575000 575000 D Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee. These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President. 1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 5, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Bryan McMichael, as Attorney-in-Fact for Dennis M. Lanfear 2024-01-08